Depuis le mercredi 8 septembre, le syndrome de Guillain-Barr\u00e9 est officiellement reconnu par l\u2019agence europ\u00e9enne du m\u00e9dicament (EMA) comme un effet secondaire \u00abtr\u00e8s rare\u00bb du vaccin contre le coronavirus produit par AstraZeneca.<\/p>\n\n\n\n
L\u2019EMA rapporte le signalement de 833 cas de ce syndrome neurologique au 31 juillet pour l\u2019administration de pr\u00e8s de 600 millions de doses du s\u00e9rum Vaxzeria produit par le laboratoire AstraZeneca \u00e0 cette p\u00e9riode.<\/p>\n\n\n\n
\u00abLe syndrome de Guillain-Barr\u00e9 devrait donc \u00eatre ajout\u00e9 aux informations sur le produit en tant qu\u2019effet secondaire de Vaxzevria\u00bb, a pr\u00e9cis\u00e9 l\u2019institution bas\u00e9e \u00e0 Amsterdam dans un communiqu\u00e9. L\u2019effet secondaire est n\u00e9anmoins consid\u00e9r\u00e9 comme \u00abtr\u00e8s rare\u00bb puisqu\u2019il intervient chez moins d\u2019une personne sur 10.000.<\/p>\n\n\n\n
UN PR\u00c9C\u00c9DENT POUR LE VACCIN DE JOHNSON & JOHNSON<\/p>\n\n\n\n
Le r\u00e9gulateur europ\u00e9en et son homologue am\u00e9ricain avaient d\u00e9j\u00e0 r\u00e9pertori\u00e9 ce syndrome comme un effet secondaire \u00abtr\u00e8s rare\u00bb du vaccin contre le Covid-19 de Johnson & Jonhson, utilisant la m\u00eame technologie ad\u00e9novirus que celui d\u2019AstraZeneca.<\/p>\n\n\n\n
L\u2019EMA recommande de mettre \u00e0 jour l\u2019avertissement sur les risques qui figurent sur le produit depuis juillet, \u00e0 destination des professionnels de sant\u00e9 et des patients. Elle conseille \u00e9galement \u00e0 ces derniers de consulter en urgence un m\u00e9decin en cas de sympt\u00f4mes de faiblesse ou de paralysie dans les extr\u00e9mit\u00e9s.<\/p>\n\n\n\n
Le syndrome de Guillain-Barr\u00e9 se caract\u00e9rise par une paralysie progressive des jambes, pouvant remonter jusqu\u2019aux muscles de la respiration, avant de s\u2019attaquer aux nerfs du cou et de la t\u00eate.<\/p>\n","protected":false},"excerpt":{"rendered":"
Depuis le mercredi 8 septembre, le syndrome de Guillain-Barr\u00e9 est officiellement reconnu par l\u2019agence europ\u00e9enne du m\u00e9dicament (EMA) comme un effet secondaire \u00abtr\u00e8s rare\u00bb du vaccin contre le coronavirus produit par AstraZeneca. L\u2019EMA rapporte le signalement de 833 cas de ce syndrome neurologique au 31 juillet pour l\u2019administration de pr\u00e8s de 600 millions de doses […]<\/p>\n","protected":false},"author":4,"featured_media":31942,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"content-type":"","jnews-multi-image_gallery":[],"jnews_single_post":{"subtitle":"","format":"standard","video":"","gallery":"","source_name":"","source_url":"","via_name":"","via_url":"","override":[{"single_blog_custom":"","sidebar":"","second_sidebar":"","share_position":"","share_float_style":"","post_date_format":"","post_date_format_custom":"","post_reading_time_wpm":"","zoom_button_out_step":"1","zoom_button_in_step":"1","number_popup_post":"1"}],"image_override":[{"single_post_thumbnail_size":"","single_post_gallery_size":""}],"trending_post_position":"","trending_post_label":"","sponsored_post_label":"","sponsored_post_name":"","sponsored_post_url":"","sponsored_post_logo":"","sponsored_post_desc":""},"jnews_primary_category":{"id":""},"jnews_override_bookmark_settings":[],"jnews_review":[],"enable_review":"","type":"","name":"","summary":"","brand":"","sku":"","good":[],"bad":[],"score_override":"","override_value":"","rating":[],"price":[],"jnews_post_split":[],"footnotes":""},"categories":[11],"tags":[],"class_list":["post-32665","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health"],"_links":{"self":[{"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=\/wp\/v2\/posts\/32665","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=32665"}],"version-history":[{"count":1,"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=\/wp\/v2\/posts\/32665\/revisions"}],"predecessor-version":[{"id":32666,"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=\/wp\/v2\/posts\/32665\/revisions\/32666"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=\/wp\/v2\/media\/31942"}],"wp:attachment":[{"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=32665"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=32665"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=32665"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}